当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2014年
8期
81-82
,共2页
帕瑞昔布钠%地佐辛%苏醒期躁动
帕瑞昔佈鈉%地佐辛%囌醒期躁動
파서석포납%지좌신%소성기조동
Parecoxib%Dezocine%Agitation during wake-up
目的:观察帕瑞昔布钠复合地佐辛预防全身麻醉苏醒期躁动的作用。方法全身麻醉下行择期甲状腺切除术患者120例随机均分为帕瑞昔布钠组(P组)、帕瑞昔布钠+地佐辛组(PD组)、地佐辛组(D组)和等容生理盐水组(C组)4组(n=30)。P组麻醉诱导前静注帕瑞昔布钠40 mg组、PD组麻醉诱导前静注帕瑞昔布钠40 mg并手术结束前30 min静注地佐辛0.1 mg/kg、D组手术结束前30 min静注地佐辛0.1 mg/kg,C组给予等容生理盐水。观察苏醒期躁动的发生情况。结果与C组比较,P、PD、D组苏醒期躁动发生显著减少(P<0.01),BCS分级和Ramsay评分更高(P<0.01),VAS评分更低(P<0.01);与P组和D组比较,PD组苏醒期躁动发生显著减少(P<0.05或0.01),BCS分级和Ramsay评分更高(P<0.05或0.01),VAS评分更低(P<0.05或0.01)。结论帕瑞昔布钠40 mg复合地佐辛0.1 mg/kg能更好地预防全身麻醉苏醒期躁动,有效提高苏醒期质量。
目的:觀察帕瑞昔佈鈉複閤地佐辛預防全身痳醉囌醒期躁動的作用。方法全身痳醉下行擇期甲狀腺切除術患者120例隨機均分為帕瑞昔佈鈉組(P組)、帕瑞昔佈鈉+地佐辛組(PD組)、地佐辛組(D組)和等容生理鹽水組(C組)4組(n=30)。P組痳醉誘導前靜註帕瑞昔佈鈉40 mg組、PD組痳醉誘導前靜註帕瑞昔佈鈉40 mg併手術結束前30 min靜註地佐辛0.1 mg/kg、D組手術結束前30 min靜註地佐辛0.1 mg/kg,C組給予等容生理鹽水。觀察囌醒期躁動的髮生情況。結果與C組比較,P、PD、D組囌醒期躁動髮生顯著減少(P<0.01),BCS分級和Ramsay評分更高(P<0.01),VAS評分更低(P<0.01);與P組和D組比較,PD組囌醒期躁動髮生顯著減少(P<0.05或0.01),BCS分級和Ramsay評分更高(P<0.05或0.01),VAS評分更低(P<0.05或0.01)。結論帕瑞昔佈鈉40 mg複閤地佐辛0.1 mg/kg能更好地預防全身痳醉囌醒期躁動,有效提高囌醒期質量。
목적:관찰파서석포납복합지좌신예방전신마취소성기조동적작용。방법전신마취하행택기갑상선절제술환자120례수궤균분위파서석포납조(P조)、파서석포납+지좌신조(PD조)、지좌신조(D조)화등용생리염수조(C조)4조(n=30)。P조마취유도전정주파서석포납40 mg조、PD조마취유도전정주파서석포납40 mg병수술결속전30 min정주지좌신0.1 mg/kg、D조수술결속전30 min정주지좌신0.1 mg/kg,C조급여등용생리염수。관찰소성기조동적발생정황。결과여C조비교,P、PD、D조소성기조동발생현저감소(P<0.01),BCS분급화Ramsay평분경고(P<0.01),VAS평분경저(P<0.01);여P조화D조비교,PD조소성기조동발생현저감소(P<0.05혹0.01),BCS분급화Ramsay평분경고(P<0.05혹0.01),VAS평분경저(P<0.05혹0.01)。결론파서석포납40 mg복합지좌신0.1 mg/kg능경호지예방전신마취소성기조동,유효제고소성기질량。
Objective To observe the effect of parecoxib combined dezocine on preventing agitation during wake-up from general anesthesia. Methods A total of 120 patients undergoing selective thyroidectomy under general anesthesia were randomly divided into 4 groups with 30 cases each. Group P received parecoxib 40 mg iv before induction of anesthesia, group PD received parecoxib 40 mg iv before induction of anesthesia plus dezocine 0.1 mg/kg iv 30 min before the end of operation, group D received dezocine 0.1 mg/kg iv 30 min before the end of operation,group C received equal volume of normal saline. The occurrence of agitation was observed during waking-up period in PACU. Results The rates of agitation was signiifcantly decreased in group s of P,PD and D than that in group of C ,The BCS and Ramsay values were higher and VAS values were lower than that in group of C. Conclusion Parecoxib 40 mg combined 0.1 mg/kg of dezocine can safely and effectively prevent the incidence of emergence agitation, so that to ensure the patients during analqesia period .